return to news
  1. 44 stocks scale to 52-week highs including KIMS and Vimta Labs as JSW Holdings leads the gains

Market News

44 stocks scale to 52-week highs including KIMS and Vimta Labs as JSW Holdings leads the gains

Upstox

3 min read | Updated on November 11, 2024, 13:57 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

On Monday, 44 stocks hit 52-week highs. Key performers, Krishna Institute hit a fresh 52-week high after the company remains confident of achieving its FY25 target. Vimta Labs and JSW Holdings scaled to a 52-week high.

Trading (10) (1).webp

44 stocks scale to 52-week highs including KIMS and Vimta Labs as JSW Holdings leads the gains

On Monday, 44 stocks reached 52-week highs even as major indices traded flat. The NIFTY50 rose by 0.70% above 24,300, while the SENSEX increased by 0.68% above the 80,000 level. The Nifty Bank also rose by 1.16%, reaching 52,144. India's volatility index, India VIX, edged down by 0.05%, staying close to the 14.5 mark.

Broader market indices remained negative, with the Nifty Midcap 100 down 0.44% and the Nifty Smallcap 100 dipping by 0.70%. Sectoral indices showed mixed performance, with Nifty IT rising by 0.90% while Nifty Media fell around 0.70%.

Here’s a look at three stocks that reached 52-week highs on Monday, November 11, 2024:

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences (KIMS) offers multidisciplinary healthcare services, providing primary, secondary, and tertiary care across tier-2 and tier-3 cities, along with a quaternary healthcare facility in tier-1 cities.

The stock surged 5.8% from its previous close, hitting a 52-week high of ₹603.45.

The stock's rise is attributed to strong quarterly performance, with PAT increasing 20% YoY for the quarter and a 23.8% YoY jump in EBITDA for Q2FY25. The CMD stated that all units are working optimally to manage patient demand across geographies, and they are confident in achieving FY25 targets. The company has also agreed to operate and manage a 150-bed Insignia Hospital, with the potential to expand to 200 beds. The super speciality hospital shall be branded as “KIMS-SIKHARA”. Currently, the company’s benefit is limited to 5% of the net revenue.

In Q2 FY25, consolidated revenue increased to ₹777 crore from ₹652 crore in Q2 FY24, a 19.13% YoY growth, while PAT rose to ₹121 crore from ₹101 crore.

The stock delivered an 8.34% market return over the past month and has a current market capitalisation of ₹23,288 crore.

Vimta Labs Ltd

This company operates in contract research and testing, covering fields such as biologics, small molecules, agrochemicals, F&B, and electronics.

The stock surged 15.9% from its previous close, reaching a 52-week high of ₹804.25.

The rise in stock price is due to a strong Q2FY25 performance, with net profit surging 140% YoY and an EBITDA margin of 35.8% for the quarter. The company aims to reach a topline of ₹500 crore by 2025/2026.

In Q2 FY25, consolidated revenue increased to ₹85 crore from ₹66 crore in Q2 FY24, a 29.3% YoY growth, while PAT rose to ₹15 crore from ₹6 crore.

The stock delivered a 37.24% market return over the past month and has a current market capitalisation of ₹1,660 crore.

JSW Holdings Ltd

This core investment company is primarily engaged in investment and financing activities.

The stock surged 10% from its previous close, reaching a 52-week high of ₹16,978.30.

JSW Holdings is set to be included in the MSCI small-cap index, expected to bring in an inflow of $7 million due to index inclusion. Though the holding company trades at a significant discount, it is currently valued at about 57% below its book value of ₹29,661.

In Q2 FY25, revenue increased to ₹162 crore from ₹89 crore in Q2 FY24, an 82% YoY growth, while PAT rose to ₹120 crore from ₹63 crore.

The stock delivered a 92.78% market return over the past month and has a current market capitalisation of ₹18,792 crore.

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story